- Atlas’ $400M growth fund will support its portfolio of biotechs FirstWord Pharma
- Atlas Venture Announces $400 Million Third Opportunity Fund Business Wire
- VC Atlas lands $400M to support existing biotech portfolio Fierce Biotech
- Biotech VC raises $400 million ‘opportunity’ fund in sign of possible industry rebound statnews.com
- Atlas Venture reels in $400M to grow its biotech startups BioPharma Dive
The wire
More investor news
Exclusive: Accel set to lead DeepMind alum’s $60m round – Sifted
Jensen Huang wants Europe to dream bigger — with Nvidia’s help – Sifted
TechCrunch Disrupt 2026: Last day – TechCrunch Venture
Prototype warfare: A defence prime’s playbook for turning technology into battlefield capability – Tech.eu
Tech Race Summit participants warn of obstacles to turning AI pilots into profits [Sponsored] – Tech.eu
Rabot Energy secures $50M to transform homes into a virtual power plant – Tech.eu